estradiol - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ESTALIS CONTINUOUS 50/140 estradiol 50mcg/day norethisterone acetate 140mcg/day patch sachet
AUST R: 70813
Active ingredients:
estradiol
norethisterone acetate

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
11 Apr 2024
to
30 Jul 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.

ESTALIS CONTINUOUS 50/250 estradiol 50mcg/day norethisterone acetate 250mcg/day patch sachet
AUST R: 70817
Active ingredients:
estradiol
norethisterone acetate

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800726369

From
02 May 2024
to
03 Aug 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.

ESTALIS SEQUI 50/140 patches sachet composite pack
AUST R: 338041
Active ingredients:
estradiol
norethisterone acetate

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
14 Feb 2024
to
02 Jul 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.

ESTALIS SEQUI 50/250 patches sachet composite pack
AUST R: 338042
Active ingredients:
estradiol
norethisterone acetate

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
29 Feb 2024
to
27 Jul 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.

ESTRADOT 100 estradiol 100 microgram transdermal drug delivery system sachet
AUST R: 338060
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
17 Jan 2024
to
15 Jul 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

ESTRADOT 25 estradiol 25 microgram transdermal drug delivery system sachet
AUST R: 338056
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
04 Aug 2023
to
12 Jul 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An alternative generic product is available. An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient 'estradiol'

ESTRADOT 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet
AUST R: 338057
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
04 Aug 2023
to
20 Sep 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.

ESTRADOT 50 estradiol 50 microgram transdermal drug delivery system sachet
AUST R: 338058
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
27 Oct 2023
to
07 Sep 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

ESTRADOT 75 estradiol 75 microgram transdermal drug delivery system sachet
AUST R: 338059
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
28 Nov 2023
to
15 Jun 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

CLIMARA 100 estradiol 100 micrograms/day transdermal drug delivery system sachet
AUST R: 56198
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Bayer Australia Ltd

Phone:
1800008757

Deletion from market:
30 Sep 2023

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

CLIMARA 25 estradiol 25 microgram/day transdermal drug delivery system sachet
AUST R: 73962
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Bayer Australia Ltd

Phone:
1800008757

Deletion from market:
31 Dec 2023

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

CLIMARA 50 estradiol 50 micrograms/day transdermal drug delivery system sachet
AUST R: 56197
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Bayer Australia Ltd

Phone:
1800 008 757

Deletion from market:
15 Mar 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

CLIMARA 75 estradiol 75 microgram/day transdermal drug delivery system sachet
AUST R: 73963
Active ingredients:
estradiol

Dosage form:
Drug delivery system, transdermal

Sponsor:
Bayer Australia Ltd

Phone:
1800008757

Deletion from market:
15 Nov 2023

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability